Henry Schein (NASDAQ:HSIC) Issues Earnings Results

Henry Schein (NASDAQ:HSIC) released its quarterly earnings data on Tuesday. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04), Zacks reports. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.66 earnings per share. Henry Schein updated its FY 2025 guidance to 4.800-4.940 EPS and its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Price Performance

HSIC stock traded up $0.08 during mid-day trading on Thursday, hitting $72.63. The stock had a trading volume of 279,944 shares, compared to its average volume of 1,645,822. The firm has a fifty day simple moving average of $74.28 and a 200 day simple moving average of $72.43. The firm has a market capitalization of $9.05 billion, a P/E ratio of 29.88, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.49.

Analyst Ratings Changes

HSIC has been the topic of a number of research reports. Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target on the stock. Wells Fargo & Company began coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Henry Schein has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.